Cargando…

Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist

BACKGROUND: The International Reporting Items for Practice Guidelines in Healthcare (RIGHT) statement is a set of recommendations for reporting in clinical practice guidelines (CPGs). We aimed to use RIGHT to evaluate the reporting quality of CPGs on prostate cancer. METHODS: We systematically searc...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kefeng, Ma, Yanfang, Yang, Yongjie, Lu, Jingli, Zhao, Jie, Du, Shuzhang, Zhang, Xuepei, Liu, Chunlei, Del Giudice, Francesco, Shiota, Masaki, Hatakeyama, Shingo, Zhang, Xiaojian, Kang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350620/
https://www.ncbi.nlm.nih.gov/pubmed/34430614
http://dx.doi.org/10.21037/atm-21-2956
_version_ 1783735805670326272
author Liu, Kefeng
Ma, Yanfang
Yang, Yongjie
Lu, Jingli
Zhao, Jie
Du, Shuzhang
Zhang, Xuepei
Liu, Chunlei
Del Giudice, Francesco
Shiota, Masaki
Hatakeyama, Shingo
Zhang, Xiaojian
Kang, Jian
author_facet Liu, Kefeng
Ma, Yanfang
Yang, Yongjie
Lu, Jingli
Zhao, Jie
Du, Shuzhang
Zhang, Xuepei
Liu, Chunlei
Del Giudice, Francesco
Shiota, Masaki
Hatakeyama, Shingo
Zhang, Xiaojian
Kang, Jian
author_sort Liu, Kefeng
collection PubMed
description BACKGROUND: The International Reporting Items for Practice Guidelines in Healthcare (RIGHT) statement is a set of recommendations for reporting in clinical practice guidelines (CPGs). We aimed to use RIGHT to evaluate the reporting quality of CPGs on prostate cancer. METHODS: We systematically searched literature databases and websites from January 1, 2018 to December 1, 2020 to identify CPGs on prostate cancer. Two investigators reviewed the identified articles and assessed the reporting quality independently by using the RIGHT checklist. We reported the proportions of guidelines that complied with each of the 35 RIGHT checklist item and the mean reporting compliance percentages for each of the seven domains of RIGHT. RESULTS: A total of 38 CPGs were included. The mean overall reporting rate over the included CPGs was 51.6%. Eighteen items were reported by more than half of the guidelines four items (1a 3, 7a and 13a) were reported by all guidelines. Items 7b (10.5%), 13b (10.5%), 14c (13.2%), and 18b (7.9%) had the lowest reporting proportions. The mean reporting rates in each RIGHT domain were 74.6% for “Basic Information”, 26.3% for “Review and quality assurance”, 59.9% for “Background”, 43.7% for “Evidence”, 43.2% for “Recommendations”, 43.4% for “Funding and declaration and management of interests”, and 43.0% for “Other information”. CONCLUSIONS: The overall adherence of CPGs on prostate cancer to RIGHT checklist is poor. Following the RIGHT checklist during the development of the guideline could improve the quality of reporting in the future.
format Online
Article
Text
id pubmed-8350620
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-83506202021-08-23 Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist Liu, Kefeng Ma, Yanfang Yang, Yongjie Lu, Jingli Zhao, Jie Du, Shuzhang Zhang, Xuepei Liu, Chunlei Del Giudice, Francesco Shiota, Masaki Hatakeyama, Shingo Zhang, Xiaojian Kang, Jian Ann Transl Med Original Article BACKGROUND: The International Reporting Items for Practice Guidelines in Healthcare (RIGHT) statement is a set of recommendations for reporting in clinical practice guidelines (CPGs). We aimed to use RIGHT to evaluate the reporting quality of CPGs on prostate cancer. METHODS: We systematically searched literature databases and websites from January 1, 2018 to December 1, 2020 to identify CPGs on prostate cancer. Two investigators reviewed the identified articles and assessed the reporting quality independently by using the RIGHT checklist. We reported the proportions of guidelines that complied with each of the 35 RIGHT checklist item and the mean reporting compliance percentages for each of the seven domains of RIGHT. RESULTS: A total of 38 CPGs were included. The mean overall reporting rate over the included CPGs was 51.6%. Eighteen items were reported by more than half of the guidelines four items (1a 3, 7a and 13a) were reported by all guidelines. Items 7b (10.5%), 13b (10.5%), 14c (13.2%), and 18b (7.9%) had the lowest reporting proportions. The mean reporting rates in each RIGHT domain were 74.6% for “Basic Information”, 26.3% for “Review and quality assurance”, 59.9% for “Background”, 43.7% for “Evidence”, 43.2% for “Recommendations”, 43.4% for “Funding and declaration and management of interests”, and 43.0% for “Other information”. CONCLUSIONS: The overall adherence of CPGs on prostate cancer to RIGHT checklist is poor. Following the RIGHT checklist during the development of the guideline could improve the quality of reporting in the future. AME Publishing Company 2021-07 /pmc/articles/PMC8350620/ /pubmed/34430614 http://dx.doi.org/10.21037/atm-21-2956 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Liu, Kefeng
Ma, Yanfang
Yang, Yongjie
Lu, Jingli
Zhao, Jie
Du, Shuzhang
Zhang, Xuepei
Liu, Chunlei
Del Giudice, Francesco
Shiota, Masaki
Hatakeyama, Shingo
Zhang, Xiaojian
Kang, Jian
Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist
title Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist
title_full Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist
title_fullStr Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist
title_full_unstemmed Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist
title_short Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist
title_sort evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the right checklist
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350620/
https://www.ncbi.nlm.nih.gov/pubmed/34430614
http://dx.doi.org/10.21037/atm-21-2956
work_keys_str_mv AT liukefeng evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT mayanfang evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT yangyongjie evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT lujingli evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT zhaojie evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT dushuzhang evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT zhangxuepei evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT liuchunlei evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT delgiudicefrancesco evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT shiotamasaki evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT hatakeyamashingo evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT zhangxiaojian evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist
AT kangjian evaluationofthereportingqualityofclinicalpracticeguidelinesonprostatecancerusingtherightchecklist